AUTHOR CORRECTION
Volume 65, no. 7, e02587-20, 2021, https://doi.org/10.1128/AAC.02587-20. In Table 4, a single methicillin-susceptible Staphylococcus aureus isolate inhibited by 0.12 μg/ml of exebacase is presented, and the remaining 148 isolates tested have an exebacase MIC range of 0.25 to 1 μg/ml. Further investigation of the isolate with an exebacase MIC of 0.12 μg/ml to confirm bacterial identification (by MALDI-TOF) and MIC revealed the isolate to be Staphylococcus pseudintermedius. Based on this finding, the authors wish to correct Table 4 and the corresponding text that refers to the S. aureus MIC data accordingly. With these corrections, the interpretation and conclusions of the article remain the same.
TABLE 4.
Exebacase MICs determined in CAMHB-HSD using frozen-form panels
| Organism | n | No. with exebacase MIC (μg/ml)a |
MIC (μg/ml) |
||||
|---|---|---|---|---|---|---|---|
| 0.25 | 0.5 | 1 | 50% | 90% | Range | ||
| S. aureus | 148 | 5 | 124 | 19 | 0.5 | 1 | 0.25–1 |
| MSSA | 73 | 4 | 62 | 7 | 0.5 | 0.5 | 0.25–1 |
| MRSA | 75 | 1 | 62 | 12 | 0.5 | 1 | 0.25–1 |
No isolates had MICs of 0.12 or 2 μg/ml.
There are four instances in the article denoting the total number of S. aureus isolates as 149; this should be corrected to 148 isolates, as follows: (1) last paragraph of the introductory section, “…MIC distribution generated by testing 149 S. aureus clinical isolates…” should read “…MIC distribution generated by testing 148 S. aureus clinical isolates…”; (2) in the Results section, the paragraph header “Exebacase in vitro activity against 149 clinical S. aureus isolates” should read “Exebacase in vitro activity against 148 clinical S. aureus isolates”; (3) in Table 4, the n value for the total number of S. aureus isolates tested should be 148; and (4) in the first paragraph of Materials and Methods, “The collection of 149 clinical S. aureus isolates…” should read “The collection of 148 clinical S. aureus isolates…”
There are three instances in the article denoting 74 MSSA; this should be changed to 73 MSSA, as follows: (1) in the Results section, in the paragraph “Exebacase in vitro activity against 148 clinical S. aureus isolates,” “74 MSSA” should read “73 MSSA”: (2) in Table 4, the n value for MSSA isolates tested should be 73; and (3) in the first paragraph of Materials and Methods, “74 MSSA” should read “73 MSSA.”
Table 4 should appear as shown below.